Skip to content

Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01851967
Enrollment
112
Registered
2013-05-13
Start date
2014-09-30
Completion date
2016-11-30
Last updated
2016-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

Major depressive disorder, Cognitive behavioral therapy, Computerized CBT, Online CBT

Brief summary

This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese Americans in the Boston area. Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules. Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking. Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.

Interventions

OTHERMoodGYM

MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Resident of the US, but self-identified as Chinese origin * At least 18 years of age * Proficiency in Chinese, including the ability to read Chinese * Access to computer and internet * Scores \> 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)

Exclusion criteria

* Current ongoing psychiatric or psychological treatment * Using illicit drugs or consumption \> 3 standard drinks in a day * Currently experiencing a psychotic illness * Past or current history of schizophrenia or bipolar disorder * ECT during the last year * Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment

Design outcomes

Primary

MeasureTime frameDescription
Change in Center for Epidemiologic Studies Depression Scale (CES-D)Weeks 0, 6 (pre/post)The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.

Countries

China, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026